Universe Pharmaceuticals/$UPC
1D1W1MYTD1Y5YMAX
Capital at risk
About Universe Pharmaceuticals
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
- Ticker
- $UPC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Ji'An, China
- Website
- www.universe-pharmacy.com
UPC Metrics
BasicAdvanced
$24M
-
-$3.45
1.59
-
Price and volume
Market cap
$24M
Beta
1.59
52-week high
$17.96
52-week low
$2.00
Average daily volume
216K
Financial strength
Current ratio
4.046
Quick ratio
3.245
Long term debt to equity
0.039
Total debt to equity
0.172
Interest coverage (TTM)
-7.28%
Profitability
EBITDA (TTM)
-1.61
Gross margin (TTM)
36.52%
Net profit margin (TTM)
-10.95%
Operating margin (TTM)
-11.78%
Management effectiveness
Return on assets (TTM)
-1.72%
Return on equity (TTM)
-3.50%
Valuation
Price to revenue (TTM)
0.154
Price to book
0.05
Price to tangible book (TTM)
0.05
Price to free cash flow (TTM)
-0.22
Free cash flow yield (TTM)
-454.46%
Free cash flow per share (TTM)
-22.086
Growth
Revenue change (TTM)
-8.04%
Earnings per share change (TTM)
-158.45%
3-year revenue growth (CAGR)
-19.81%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.